• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYC 失活可逆转肿瘤发生。

Inactivation of MYC reverses tumorigenesis.

机构信息

Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

J Intern Med. 2014 Jul;276(1):52-60. doi: 10.1111/joim.12237.

DOI:10.1111/joim.12237
PMID:24645771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4065197/
Abstract

The MYC proto-oncogene is an essential regulator of many normal biological programmes. MYC, when activated as an oncogene, has been implicated in the pathogenesis of most types of human cancers. MYC overexpression in normal cells is restrained from causing cancer through multiple genetically and epigenetically controlled checkpoint mechanisms, including proliferative arrest, apoptosis and cellular senescence. When pathologically activated in the correct epigenetic and genetic contexts, MYC bypasses these mechanisms and drives many of the 'hallmark' features of cancer, including uncontrolled tumour growth associated with DNA replication and transcription, cellular proliferation and growth, protein synthesis and altered cellular metabolism. MYC also dictates tumour cell fate by enforcing self-renewal and by abrogating cellular senescence and differentiation programmes. Moreover, MYC influences the tumour microenvironment, including activating angiogenesis and suppressing the host immune response. Provocatively, brief or even partial suppression of MYC back to its physiological levels of activation can lead to the restoration of intrinsic checkpoint mechanisms, resulting in acute and sustained tumour regression associated with tumour cells undergoing proliferative arrest, differentiation, senescence and apoptosis, as well as remodelling of the tumour microenvironment, recruitment of an immune response and shutdown of angiogenesis. Hence, tumours appear to be addicted to the MYC oncogene because of both tumour cell intrinsic and host-dependent mechanisms. MYC is important for the regulation of both the initiation and maintenance of tumorigenesis.

摘要

原癌基因 MYC 是许多正常生物学程序的重要调节因子。作为癌基因激活的 MYC,与大多数类型的人类癌症的发病机制有关。MYC 在正常细胞中的过度表达受到多种遗传和表观遗传控制的检查点机制的限制,包括增殖停滞、细胞凋亡和细胞衰老。当在正确的表观遗传和遗传背景下病理性激活时,MYC 绕过这些机制,并驱动许多“标志性”的癌症特征,包括与 DNA 复制和转录、细胞增殖和生长、蛋白质合成和细胞代谢改变相关的不受控制的肿瘤生长。MYC 还通过强制自我更新和废除细胞衰老和分化程序来决定肿瘤细胞的命运。此外,MYC 影响肿瘤微环境,包括激活血管生成和抑制宿主免疫反应。挑衅性的是,即使是短暂的或部分抑制 MYC 使其回到其生理激活水平,也可以导致内在检查点机制的恢复,导致肿瘤的急性和持续消退,与肿瘤细胞经历增殖停滞、分化、衰老和凋亡以及肿瘤微环境的重塑、免疫反应的募集和血管生成的关闭有关。因此,由于肿瘤细胞内在和宿主依赖性机制,肿瘤似乎对 MYC 癌基因上瘾。MYC 对于肿瘤发生的启动和维持的调节都很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/94e51f45a2e0/nihms576190f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/6060d293a29a/nihms576190f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/5c1c7c9720fb/nihms576190f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/94e51f45a2e0/nihms576190f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/6060d293a29a/nihms576190f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/5c1c7c9720fb/nihms576190f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb4/4065197/94e51f45a2e0/nihms576190f3.jpg

相似文献

1
Inactivation of MYC reverses tumorigenesis.MYC 失活可逆转肿瘤发生。
J Intern Med. 2014 Jul;276(1):52-60. doi: 10.1111/joim.12237.
2
MYC activation is a hallmark of cancer initiation and maintenance.MYC激活是癌症起始和维持的一个标志。
Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a014241. doi: 10.1101/cshperspect.a014241.
3
Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.c-Myc的短暂失活不足以使c-Myc诱导的胰岛和皮肤表皮肿瘤持续消退。
BMC Biol. 2004 Dec 21;2:26. doi: 10.1186/1741-7007-2-26.
4
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.在急性白血病小鼠模型中,p19ARF是细胞衰老以及与MYC失活相关的先天免疫反应的关键介质。
Oncotarget. 2015 Feb 28;6(6):3563-77. doi: 10.18632/oncotarget.2969.
5
MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.MYC失活通过肿瘤细胞内在机制和宿主依赖机制引发癌基因成瘾。
Genes Cancer. 2010 Jun;1(6):597-604. doi: 10.1177/1947601910377798.
6
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.MYC和K-Ras癌基因的联合失活可逆转肺腺癌和淋巴瘤的肿瘤发生。
PLoS One. 2008 May 7;3(5):e2125. doi: 10.1371/journal.pone.0002125.
7
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.MYC失活揭示了肝细胞癌中的多能分化和肿瘤休眠。
Nature. 2004 Oct 28;431(7012):1112-7. doi: 10.1038/nature03043. Epub 2004 Oct 10.
8
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression.转录激活因子 4 (ATF4)在肿瘤进展过程中把 MYC 依赖性翻译活性与能量需求联系起来。
Nat Cell Biol. 2019 Jul;21(7):889-899. doi: 10.1038/s41556-019-0347-9. Epub 2019 Jul 1.
9
MYC, metabolism, cell growth, and tumorigenesis.MYC、代谢、细胞生长和肿瘤发生。
Cold Spring Harb Perspect Med. 2013 Aug 1;3(8):a014217. doi: 10.1101/cshperspect.a014217.
10
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.肿瘤休眠、致癌基因成瘾、细胞衰老和自我更新程序。
Adv Exp Med Biol. 2013;734:91-107. doi: 10.1007/978-1-4614-1445-2_6.

引用本文的文献

1
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.WDHD1 的综合生物信息学分析:一种用于泛癌预后、诊断和免疫治疗的潜在生物标志物。
World J Surg Oncol. 2023 Sep 27;21(1):309. doi: 10.1186/s12957-023-03187-3.
2
GeNetOntology: identifying affected gene ontology terms via grouping, scoring, and modeling of gene expression data utilizing biological knowledge-based machine learning.基因本体论:通过利用基于生物知识的机器学习对基因表达数据进行分组、评分和建模来识别受影响的基因本体术语。
Front Genet. 2023 Aug 21;14:1139082. doi: 10.3389/fgene.2023.1139082. eCollection 2023.
3

本文引用的文献

1
Cdc45 is a critical effector of myc-dependent DNA replication stress.Cdc45 是 Myc 依赖性 DNA 复制应激的关键效应因子。
Cell Rep. 2013 May 30;3(5):1629-39. doi: 10.1016/j.celrep.2013.04.002. Epub 2013 May 2.
2
Hepatotoxicity with combination of vemurafenib and ipilimumab.维莫非尼与伊匹木单抗联合使用时的肝毒性。
N Engl J Med. 2013 Apr 4;368(14):1365-6. doi: 10.1056/NEJMc1302338.
3
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.抑制 Myc 家族蛋白可消除小鼠中 KRas 驱动的肺癌。
Zinc Finger E-Box Binding Homeobox Family: Non-Coding RNA and Epigenetic Regulation in Gliomas.
锌指E盒结合同源框家族:胶质瘤中的非编码RNA与表观遗传调控
Biomedicines. 2023 May 5;11(5):1364. doi: 10.3390/biomedicines11051364.
4
Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers.C-MYC、N-MYC和L-MYC表达的改变及共现与多种癌症的临床结局相关。
Int J Stem Cells. 2023 May 30;16(2):215-233. doi: 10.15283/ijsc22188. Epub 2023 Apr 30.
5
Cell senescence-associated genes predict the malignant characteristics of glioblastoma.细胞衰老相关基因可预测胶质母细胞瘤的恶性特征。
Cancer Cell Int. 2022 Dec 16;22(1):411. doi: 10.1186/s12935-022-02834-1.
6
Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison.工程化肿瘤细胞衍生的抗癌疫苗:以毒攻毒的艺术。
Bioact Mater. 2022 Oct 26;22:491-517. doi: 10.1016/j.bioactmat.2022.10.016. eCollection 2023 Apr.
7
MYC and therapy resistance in cancer: risks and opportunities.癌中的 MYC 与治疗抵抗:风险与机遇。
Mol Oncol. 2022 Nov;16(21):3828-3854. doi: 10.1002/1878-0261.13319. Epub 2022 Oct 20.
8
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.MYC 癌基因引发的肿瘤发生与胚胎、核糖体生物发生和组织谱系去分化基因表达变化有关。
Oncogene. 2022 Nov;41(45):4960-4970. doi: 10.1038/s41388-022-02458-9. Epub 2022 Oct 7.
9
Computer Image Analysis Reveals C-Myc as a Potential Biomarker for Discriminating between Keratoacanthoma and Cutaneous Squamous Cell Carcinoma.计算机图像分析显示 C-Myc 可作为鉴别角化棘皮瘤和皮肤鳞状细胞癌的潜在生物标志物。
Biomed Res Int. 2022 Aug 23;2022:3168503. doi: 10.1155/2022/3168503. eCollection 2022.
10
Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.无论是否发生突变,直接导致肿瘤状态(即细胞永生化和自主性)的因素仍然未知,这应该是我们研究中的优先事项。
J Cancer. 2022 Jul 4;13(9):2810-2843. doi: 10.7150/jca.72628. eCollection 2022.
Genes Dev. 2013 Mar 1;27(5):504-13. doi: 10.1101/gad.205542.112.
4
Drugging the undruggable: transcription therapy for cancer.攻克难成药靶点:癌症的转录疗法
Biochim Biophys Acta. 2013 Jan;1835(1):76-85. doi: 10.1016/j.bbcan.2012.11.002. Epub 2012 Nov 9.
5
Functional genomics identifies therapeutic targets for MYC-driven cancer.功能基因组学确定了 MYC 驱动型癌症的治疗靶点。
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9545-50. doi: 10.1073/pnas.1121119109. Epub 2012 May 23.
6
MYC on the path to cancer.癌基因 MYC 研究进展。
Cell. 2012 Mar 30;149(1):22-35. doi: 10.1016/j.cell.2012.03.003.
7
Combining immunotherapy and targeted therapies in cancer treatment.将免疫疗法和靶向疗法相结合用于癌症治疗。
Nat Rev Cancer. 2012 Mar 22;12(4):237-51. doi: 10.1038/nrc3237.
8
Immunology in the clinic review series; focus on cancer: multiple roles for the immune system in oncogene addiction.临床免疫学综述系列;聚焦癌症:免疫系统在致癌基因成瘾中的多种作用。
Clin Exp Immunol. 2012 Feb;167(2):188-94. doi: 10.1111/j.1365-2249.2011.04514.x.
9
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.SUMOylation 依赖性转录亚程序是 Myc 驱动的肿瘤发生所必需的。
Science. 2012 Jan 20;335(6066):348-53. doi: 10.1126/science.1212728. Epub 2011 Dec 8.
10
Survival and death signals can predict tumor response to therapy after oncogene inactivation.存活和死亡信号可以预测癌基因失活后肿瘤对治疗的反应。
Sci Transl Med. 2011 Oct 5;3(103):103ra99. doi: 10.1126/scitranslmed.3002018.